Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 32, 2022 - Issue 6
Submit an article Journal homepage
290
Views
4
CrossRef citations to date
0
Altmetric
Review

Malaria transmission blocking compounds: a patent review

Sara ConsalviDepartment of Chemistry and Technologies of Drug, Sapienza University of Rome, Rome, ItalyView further author information
,
Chiara TammaroDepartment of Chemistry and Technologies of Drug, Sapienza University of Rome, Rome, ItalyView further author information
,
Federico AppetecchiaDepartment of Chemistry and Technologies of Drug, Sapienza University of Rome, Rome, ItalyView further author information
,
Mariangela BiavaDepartment of Chemistry and Technologies of Drug, Sapienza University of Rome, Rome, ItalyView further author information
&
Giovanna PoceDepartment of Chemistry and Technologies of Drug, Sapienza University of Rome, Rome, ItalyCorrespondence[email protected]
View further author information
Pages 649-666 | Received 29 Nov 2021, Accepted 01 Mar 2022, Published online: 11 Mar 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Pinky Gehlot & Vivek K. Vyas. (2023) Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors as antimalarial agents. Expert Opinion on Therapeutic Patents 33:9, pages 579-596.
Read now
Elizabeth A. Lopes, Maria M. M. Santos & Mattia Mori. (2023) Antimalarial drugs: what’s new in the patents?. Expert Opinion on Therapeutic Patents 33:3, pages 151-168.
Read now
Claudiu T. Supuran. (2023) Antiprotozoal drugs: challenges and opportunities. Expert Opinion on Therapeutic Patents 33:3, pages 133-136.
Read now

Articles from other publishers (1)

Rohitas Deshmukh. (2023) Exploring the potential of antimalarial nanocarriers as a novel therapeutic approach. Journal of Molecular Graphics and Modelling 122, pages 108497.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.